For the Inventor, By the Inventor

Enter assignee name

Incheon, South Korea

Celltrion Inc.

USPTO Granted Patents = 30

CIPO Patents = 1

EPO Patents = 14

Trademarks = 66

Forward Citations = 52

Loading Chart...

Loading Chart...

121 inventors (with patents filed for the assignee):

Shin Jae Chang (11 out of 11 patents)

Su Jung Kim (6 out of 7 patents)

Joon Won Lee (6 out of 6 patents)

4. Won Yong Han (6 out of 6 patents)

5. Jun Seok Oh (6 out of 6 patents)

6. Yeon Kyeong Shin (6 out of 6 patents)

7. Kye Sook Yi (6 out of 6 patents)

8. So Young Kim (6 out of 41 patents)

9. Kwang Woo Kim (5 out of 5 patents)

10. Seung Suh Hong (5 out of 5 patents)

11. Joo Hyuck Lim (4 out of 4 patents)

12. Young Jun Park (4 out of 31 patents)

13. Ki Sung Kwon (4 out of 6 patents)

14. Hyun Joo Lee (4 out of 4 patents)

15. Sung Ho Moon (3 out of 279 patents)

30 patents: Sort by Forward Citations

1. 12486237 - Polymorphic form of (-)-cibenzoline succinate (2025-12-02),

2. 12419863 - Pharmaceutical composition for use in treatment of hypertrophic cardiomyopathy (2025-09-23),

3. 12188036 - Expression cassette for production of high-expression and high-functionality target protein and use thereof (2025-01-07),

4. 12157764 - Dosing regimen for treating influenza virus diseases (2024-12-03),

5. 12065482 - Stable liquid pharmaceutical formulation of anti-influenza virus antibody (2024-08-20),

6. 11986523 - Stable liquid formula comprising anti-TNFa antibody, acetate buffer, and glycine (2024-05-21),

7. 11951207 - Stable liquid pharmaceutical preparation (2024-04-09),

8. 11730698 - Stable liquid pharmaceutical preparation (2023-08-22),

9. 11712407 - Hybrid-type multi-lamellar nanostructure of epidermal growth factor and liposome and method for manufacturing same (2023-08-01),

10. 11236146 - Stable pharmaceutical formulation (2022-02-01),

11. 11202751 - Whitening cosmetic composition comprisingroot extract (2021-12-21),

12. 11007136 - Cosmetic composition for wrinkle reduction containing gypenoside isolated from (2021-05-18),

13. 10980881 - Stable liquid formula having an anti-TNFalpha antibody, acetate buffer and glycine (2021-04-20),

14. 10947497 - callus extract having increased content of gallic acid, method for preparing same, and whitening cosmetic composition containing same (2021-03-16),

15. 10722571 - Rabies virus G protein epitope, and rabies virus neutralising binding molecule that binds specifically thereto (2020-07-28),

Celltrion Inc. is a global biopharmaceutical company focused on the development and commercialization of innovative and affordable biosimilar therapeutics. They strive to enhance access to essential treatments and improve the lives of patients around the world. With cutting-edge technology and extensive research capabilities, Celltrion is dedicated to creating high-quality biosimilars that meet global standards. Visit their website for more information and to explore their product portfolio.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

30 Patents

#16 in Incheon, 402-040

#440 in South Korea

#21,212 in the World

Incheon, South Korea

Celltrion Inc.

Forward Citations = 52

121 inventors:

Shin Jae Chang (11 out of 11 patents)

Su Jung Kim (6 out of 7 patents)

Joon Won Lee (6 out of 6 patents)

4. Won Yong Han (6 out of 6 patents)

5. Jun Seok Oh (6 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…